GlassScriptPhysician profile
Joel H Spielman
NPI 1568555019
$1,179.83
in general payments reported to CMS, 2019-2025
17 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $113 · 2021: $250 · 2022: $69.78 · 2023: $41.10 · 2024: $232 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $252.47 | 2019-2025 | T2 Alpha, Pangea, Alphavent |
| Depuy Synthes Sales INC. | $169.14 | 2019-2021 | |
| Horizon Therapeutics Plc | $155.33 | 2019-2021 | |
| Bioventus LLC | $146.30 | 2019-2024 | Gelsyn-3, Durolane, Bonescalpel & Sonicone (O.R.) |
| Ferring Pharmaceuticals INC. | $102.71 | 2019-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $48.32 | 2025 | Juggerknotless Soft Anchor |
| Medtronic, INC. | $42.11 | 2021-2024 | Plasmablade(Tm) |
| Surgalign Spine Technologies, INC. | $41.83 | 2020 | |
| Medacta USA, INC. | $39.29 | 2024-2025 | Nextar Shoulder |
| Vertex Pharmaceuticals Incorporated | $31.58 | 2024-2025 | |
| Avanos Medical | $29.05 | 2024 | Trivisc Sodium Hyaluronate |
| Pacira Therapeutics, INC. | $26.92 | 2019 | |
| Ossur Americas, INC. | $24.85 | 2024 | Miami J |
| Ethicon US, LLC | $20.31 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.55 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $17.39 | 2025 | |
| Baxter Healthcare | $14.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Spielman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.